← Back to articles

SAFE vs Convertible Note: Dilution Comparison for Founders

The SAFE Revolution and Why It Changed Everything

Y Combinator invented the SAFE (Simple Agreement for Future Equity) in 2010 as a response to the complexity of convertible notes. The idea was brilliant: founders and investors needed something faster, cheaper to draft, and less mathematically daunting. Instead of a debt instrument with interest rates and maturity dates, a SAFE is simply an agreement to convert to equity at a future financing event.

SAFEs were designed to be founder-friendly, and in many ways they are. There's no interest accrual, no maturity date hanging over your head like a legal sword. You raise capital, and the conversion happens cleanly when you raise your Series A. But here's what founders often miss: the simplicity of the SAFE creates a false sense of a low-cost instrument. The dilution can be severe, and most founders don't calculate it until it's too late.

According to Carta's 2024 analysis of 10,000+ funding rounds, SAFEs are used in 85%+ of pre-seed and seed financings. That's not because they're always best for founders --- it's because they're fastest and cheapest to negotiate. Most founders don't have the resources to negotiate a complex convertible note, so they take the standard SAFE terms and hope the conversion math doesn't hurt.

That hope often fails.

SAFEs Explained: The Three Critical Variables

A SAFE has three key variables that determine your dilution: the investment amount, the valuation cap, and the discount rate. Let me walk through each because the interactions matter.

Investment amount is straightforward. You're raising 500K on a SAFE. That 500K gets converted to equity based on your Series A terms.

Valuation cap is the ceiling on the price per share at conversion. If your SAFE has an 8M valuation cap and your Series A is at 20M pre-money, the cap still applies. Your SAFE converts at the better of the Series A price or the cap. This protects the investor. If you raise Series A at 20M pre-money, the cap of 8M is irrelevant (the Series A price is better for the investor). But if you raise at 5M pre-money, the cap is what matters. Common SAFE caps at pre-seed are 5M to 10M. At seed, 10M to 20M is typical. By Series A, caps are 20M to 50M. These are just ranges --- your specific cap depends on your negotiation and investor demand.

Stage	Typical Cap	Typical Discount
Pre-Seed	$5-10M	15-25%
Seed	$10-20M	10-20%
Bridge / Extension	$20-40M	5-15%

Discount rate gives the investor a reward for taking risk early. A 20% discount means the investor's SAFE converts at 80% of the Series A price. If Series A is at 10 per share, a 20% discount means the SAFE investor pays 8 per share. For pre-seed SAFEs, discount rates range from 15% to 25%. For seed, 10% to 20%. The discount is investor-friendly, not founder-friendly, so push for lower discounts if you can. Every 5% increase in discount rate costs you 0.5% to 1% in additional dilution.

Pre-Money vs Post-Money SAFEs: The Critical Distinction

This is where the confusion starts for most founders. Y Combinator's original SAFE was pre-money. In 2018, they introduced post-money SAFEs because the market demanded them. The difference is mathematical but consequential.

Pre-money SAFE: The conversion is based on your pre-money valuation at Series A. If you raise Series A at 15M pre-money, the pre-money SAFE cap applies. The math becomes complex because the SAFE is part of the "money in" that determines the Series A post-money valuation, but it converts based on the pre-money valuation. Most investors now understand this is messy, so pre-money SAFEs are rare.

Post-money SAFE: The conversion is based on the post-money valuation of Series A. If you raise 5M at a 15M pre-money valuation (20M post-money), a post-money SAFE converts based on the 20M post-money valuation. This is cleaner and more founder-friendly on the surface because the math is simpler. A 500K post-money SAFE at a 10M cap with a 20% discount: at Series A of 5M at 15M pre-money (20M post-money), the SAFE converts at 80% of 20M = 16M valuation. The 500K represents 500K/16M = 3.1% dilution. That's the math you'll see in your cap table.

Why is post-money cleaner for founders? Because you can intuit the dilution more easily. With pre-money SAFEs, the math required a spreadsheet to understand. With post-money, you can roughly estimate: my SAFE is worth SAFE-size divided by the post-money valuation. Not perfectly accurate, but close.

Convertible Notes: The Traditional Alternative

Before SAFEs, convertible notes were the standard way to raise early-stage capital. They're still used, especially in certain markets and by certain investors. A convertible note is a debt instrument. You're borrowing money that converts to equity at a future event.

A typical convertible note has: a principal amount (500K), an interest rate (4% to 8% annually is standard), a valuation cap (similar to SAFEs), a discount rate (15% to 25%), and a maturity date (typically 2 to 5 years, though most convert before maturity).

The interest rate is the killer difference. Over 2 years, a 500K note at 6% interest accrues 60K in interest. That 60K gets added to the 500K, so you're actually converting 560K at Series A. The effective cost is visible. For a founder, that's a 12% cost of capital over 2 years, which matters. For an investor, it's compensation for the risk of early investment.

According to SaaStr data, convertible note interest rates have ranged from 4% at the low end (very founder-friendly, rare) to 8% at the high end (investor-friendly, common). Most pre-seed and seed convertible notes in 2024 sit at 5% to 6.5%. The interest accrues whether you're growing fast or struggling, which can be painful if you don't hit Series A on time.

Maturity dates on convertible notes create legal pressure. If you haven't raised Series A by the maturity date, the note technically comes due. In practice, founders and investors renegotiate, but this creates tension. SAFEs have no maturity date, which is why they became so popular --- one less thing to manage.

The Dilution Math: Real Numbers You Need to Understand

Let me walk through a concrete example. You're a pre-seed founder. You raise 500K on a SAFE: 500K investment, 8M valuation cap, 20% discount. Twelve months later, you're raising Series A: 5M at 15M pre-money valuation (20M post-money). Using a post-money SAFE:

Series A post-money valuation: 20M
Discount applied to cap: 80% of 8M (capped at Series A price)
Series A price per share: 20M post-money / (15M pre-money / share price)
Your SAFE conversion price: 20M * 80% = 16M effective valuation
SAFE dilution: 500K / 16M = 3.1%

But that's just the SAFE. The Series A itself dilutes you another 20% (5M / 25M total funding in the round). Combined, you've gone from 100% ownership to roughly 77% ownership. That's not dramatic, but it's real.

Step	Pre-Money SAFE	Post-Money SAFE
1. Series A Pre-Money	$15M	$15M
2. Apply 20% Discount to Cap	$8M * 80% = $6.4M	$20M * 80% = $16M
3. SAFE Dilution ($500K)	7.8% founder loss	3.1% founder loss
4. Series A Dilution	20% additional	20% additional

Now imagine you raised three SAFEs before Series A: one for 500K at 8M cap, one for 300K at 10M cap, one for 200K at 12M cap. Total 1M raised on SAFEs. At Series A, you're converting 1M across three different caps. The stacking effect is significant. Your founders' ownership drops to roughly 70% by Series A. Two more rounds and you're sub-30%, which is typical but worth understanding in advance.

Using the calculator at /tools/#safe, you can input your specific SAFE terms (instrument type, investment amount, valuation cap, discount rate) and see exactly how much ownership you retain after conversion into your Series A (pre-money valuation, investment amount). The calculator accounts for post-money vs pre-money, multiple stacked SAFEs, and shows you the dilution impact on your cap table.

SAFE Caps by Stage: What's Normal?

The valuation cap sets the floor on the investor's entry price. Lower caps are better for investors, higher caps are better for founders. What should you expect?

Pre-seed SAFEs: 5M to 10M valuation caps are normal. If you're a strong team with a clear problem, aim for 6M to 8M. If you're at a top-tier accelerator, you might push to 5M to 7M. YC companies often get 7M to 10M post-demo day, depending on traction.

Seed SAFEs: 10M to 20M caps are typical. A company with early traction (first customers, 50K to 200K ARR) might negotiate 12M to 15M. A more mature seed company (500K+ ARR) might push to 18M to 25M.

Seed extension / bridge SAFEs: 20M to 40M caps if you're strong. These are less common now but some companies raise bridge SAFEs before Series A. The cap should reflect your Series A likely valuation range.

These are medians and ranges. Your specific cap depends on your market, team strength, traction, and who you're raising from. A SAFE cap negotiation is about anchoring to comparable companies. Use PitchBook or Carta data to show your investor what similar companies raised at. "We're seeing comparable SaaS companies with 200K ARR get 12M caps, and we're at 150K and earlier, so 10M seems fair" is a reasonable founder pitch.

Discount Rates: The Often-Overlooked Cost

A 10% difference in discount rate between a 10% and 20% discount costs you roughly 0.5% to 1% in dilution, depending on the Series A valuation. That seems small until you compound it across multiple investors and rounds. A founder raising multiple SAFEs with different discount rates (because different investors negotiate differently) can end up with a messy cap table and 15%+ dilution from the discount effect alone.

Standard discount rates in the market are: pre-seed 15% to 25%, seed 10% to 20%. Push for the lower end. If an investor asks for 20% discount at pre-seed, ask why. If they're taking real risk, 15% is reasonable. If you're a YC company with clear product-market fit, push for 10% to 15%. Every percentage point matters.

When Convertible Notes Make Sense

SAFEs are now the default, but convertible notes still have uses. If you're raising from an investor who insists on a note, or if you're in a market where notes are standard (some regions outside the US still use notes heavily), you need to understand the terms.

A convertible note at 500K, 6% interest, 10M cap, 20% discount, 3-year maturity. You're paying 6% annually for the capital. Over 3 years, that's 90K in accrued interest. At conversion, you're converting 590K instead of 500K. That's an 18% cost of capital, which is real. But if your alternative is a SAFE at a 6M cap (aggressive founder-friendly cap), the convertible note with a 10M cap might actually be better for the investor, leaving you in a better position.

Interest rates on convertible notes have compressed over the years. In 2016-2018, you'd see 5% to 7% commonly. By 2024, the market is more competitive, and 4% to 6% is standard, with 4% to 5% for founder-friendly investors. If someone offers you an 8% rate, that's investor-friendly. Push back.

Stacking SAFEs: The Hidden Dilution Multiplier

Most pre-seed and seed founders raise from multiple investors. Each investor gets a SAFE. If you raise from five investors at 100K each (500K total), you have five SAFEs with potentially different caps and discount rates. At Series A, they all convert simultaneously. This is where cap tables get messy.

Founder + 500K SAFE at 8M cap, 20% discount + 300K SAFE at 10M cap, 15% discount + 200K SAFE at 10M cap, 15% discount. Total 1M raised. At Series A of 5M at 15M pre-money, your founder ownership drops from 100% to roughly 70%. That's across the three SAFEs combined. Track your SAFE stack continuously. Every new SAFE you take is cumulative dilution at Series A.

Pro tip: many founders use Carta or a similar cap table software to model this. Input each SAFE as you raise, and Carta shows you the projected ownership at Series A under different valuation scenarios. This removes the guesswork. If you see that your fourth SAFE will drop you below 65% ownership at Series A, you'll know before you sign. You can decide whether that's worth the capital, or whether you should seek fewer, larger checks to hit your goal with fewer SAFEs.

Using the SAFE vs Convertible Comparison Tool

The calculator at /tools/#safe lets you compare instruments side by side. Input your SAFE terms on one side, convertible note terms on the other, and specify your Series A assumptions. The tool shows you the dilution impact of each and helps you negotiate from a position of real understanding.

The tool inputs are: instrument type (SAFE or convertible note), investment amount, valuation cap, discount rate, maturity date (for notes), interest rate (for notes), next round pre-money valuation, and next round investment. It outputs founder ownership at conversion, actual dilution percentage, and effective cost of capital. This removes any calculation error from your decision.

What Most Founders Get Wrong About SAFEs

The biggest mistake is signing SAFEs without understanding the stacking effect. You take a 500K SAFE at 8M cap and feel good. The cap is high enough that you don't feel like you're giving up much ownership. Then you take another 500K SAFE at 10M cap. Then another 300K at 12M cap. You've raised 1.3M and you haven't raised Series A yet. When Series A comes and all three SAFEs convert, the cumulative dilution is 15% to 20% just from those notes, before the Series A itself (which is another 20-30% dilution).

The second mistake is not tracking MFN (Most Favored Nation) clauses. Many SAFEs include an MFN provision: if you raise another SAFE at better terms, all previous SAFE investors get the better terms automatically. This means if you negotiate a 15% cap with one investor early on, and a 12M cap with a late investor, the first investor's SAFE cap drops to 12M to match. MFN clauses create a race to the bottom on terms. Every new investor you take at slightly better terms ratchets down all previous investor terms. It's exhausting. Be aware of it and include or exclude MFN based on your strategy.

The third mistake is assuming the valuation cap is a ceiling on your Series A valuation. It's not. The cap is a ceiling on the conversion price. Your Series A can be at any valuation. If you raise Series A at 50M pre-money and your SAFE cap is 10M, the cap doesn't prevent the high Series A valuation --- it just limits how much the SAFE investor benefits. The cap becomes irrelevant. This is important: a high Series A valuation with a low SAFE cap is actually bad for the founder because the SAFE investor gets a massive discount and you all dilute more.

Summary

SAFEs and convertible notes are the standard way to raise pre-seed and seed capital. SAFEs are simpler and more founder-friendly in structure, dominating 85%+ of early rounds per Carta data. But both instruments can hide significant dilution. The valuation cap, discount rate, and interaction with your Series A terms determine your actual cost. Model your dilution before signing. Use the comparison calculator at /tools/#safe to input your specific instrument terms and Series A assumptions. Understand the pre-money vs post-money distinction. Track your SAFE stack carefully. Every SAFE or convertible note is cumulative ownership loss at Series A. Smart founders do the math in advance and negotiate hard on caps and discount rates. The difference between a 8M cap at 20% discount and a 10M cap at 15% discount can mean 2-3% of your company at Series A. Over the course of a 3-round funding journey, those percentage points compound.